Dementia prevention vaccine ready for human trials, researchers say

A vaccine designed to prevent dementia is ready to enter the human trial stage within two years after successful tests on mice, researchers say. The study, published in the journal “Alzheimer’s Research & Therapy” explores the 20 years of U.S.-backed research that was mostly carried out at South Australia’s Flinders University by Nikolai Petrovsky. The treatment consists of a combination of two drugs that target and remove “brain plaque” and tau protein ag